These drugs are more than merely a potential breakthrough in leukemia treatment. They are a completely new class of drugs: protein-protein inhibitors that target a part of the enzyme away from its ...

The second type is the 'predictive' biomarker, which allows the identification of individuals who benefit from a particular drug or treatment ... expression Molecular classification of breast ...